Chronic hepatitis in interferon-gamma transgenic mice is associated with elevated CPP32-like activity and interleukin-1beta-converting enzyme activity suppression
Related Experiment Video
Updated: Oct 23, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
T Okamoto1, Y Nakano, T Yamakawa
1Research Laboratories, Nippon Chemiphar Co., Ltd., Saitama, Japan.
Abstract:
Interferon-gamma (IFN-gamma) transgenic mice strongly express IFN-gamma in the liver and develop chronic hepatitis. Furthermore, hepatocyte apoptosis was shown by the TdT-mediated dUTP-biotin nick endlabeling method. In the present study, interleukin-1beta-converting enzyme (ICE) and CPP32-like protease activities in the liver of IFN-gamma transgenic mice were measured, using the synthetic substrates Ac-YVAD-MCA and Ac-DEVD-MCA. Plasma aspartate aminotransferase and alanine aminotransferase activities as well as CPP32-like activity were significantly elevated, while ICE activity was significantly reduced. The addition of the ICE inhibitor Ac-YVAD-CHO to IFN-gamma transgenic mouse liver cell cytosol had no effect on the CPP32 activity, in contrast to a CPP32 inhibitor. The present results indicate that chronic hepatitis in the IFN-gamma transgenic mouse is associated with a decrease in ICE and induction of CPP32-like activity.
Insights
Interferon-gamma (IFN-gamma) transgenic mice develop chronic hepatitis. This study found reduced interleukin-1beta-converting enzyme (ICE) and increased CPP32-like protease activity in their livers, linking these protease changes to liver injury.
Area of Science:
- Hepatology
- Immunology
- Molecular Biology
Background:
- Interferon-gamma (IFN-gamma) transgenic mice exhibit liver expression of IFN-gamma, leading to chronic hepatitis.
- Hepatocyte apoptosis is a key feature of liver damage in these mice.
Purpose of the Study:
- To investigate the roles of interleukin-1beta-converting enzyme (ICE) and CPP32-like protease activity in the pathogenesis of chronic hepatitis in IFN-gamma transgenic mice.
- To elucidate the specific protease activities contributing to liver injury.
Main Methods:
- Measurement of ICE and CPP32-like protease activities in liver cytosol using synthetic substrates (Ac-YVAD-MCA and Ac-DEVD-MCA).
- Assessment of plasma aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities.
- Inhibition studies using Ac-YVAD-CHO (ICE inhibitor) and a CPP32 inhibitor on liver cell cytosol.
Main Results:
- Significantly elevated plasma AST and ALT activities, indicative of liver damage.
- Significantly reduced ICE activity and significantly induced CPP32-like protease activity in the liver of IFN-gamma transgenic mice.
- ICE inhibition did not affect CPP32 activity, whereas CPP32 inhibition did, suggesting distinct roles.
Conclusions:
- Chronic hepatitis in IFN-gamma transgenic mice is characterized by a decrease in ICE activity.
- The induction of CPP32-like protease activity is associated with liver injury in this model.
- These findings highlight the differential involvement of caspases in IFN-gamma-mediated liver disease.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hepatitis

